Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: An immunohistochemical study

American Journal of Clinical Pathology

Volumn 122, Issue 1, 2004, Pages 61-69

  Lau, Sean K ^a   Weiss, Lawrence M ^a   Chu, Peiguo G ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Carcinomas; Immunohistochemistry; MUC1; MUC2; MUC5AC; Mucin

Indexed keywords

MUCIN; MUCIN 1; MUCIN 2; MUCIN 5AC;

ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; COLON CARCINOMA; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TISSUE SPECIFICITY; UROGENITAL TRACT CANCER; UTERUS CARCINOMA;

EID: 3042845879     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/9R6673QEC06D86Y4     Document Type: Article

References (70)

1. Devine PL, McKenzie IFC. Mucins: structure, function, and associations with malignancy. Bioessays. 1992;14:619-625.
2. Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol. 1994;17:153-180.
3. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol. 1995;57:607-634.
4. Seregni E, Botti C, Massaron S, et al. Structure, function, and gene expression of epithelial mucins. Tumori. 1997;83:625-632.
5. Van Klinken BJW, Einerhand AWC, Buller HA, et al. Strategic biochemical analysis of mucins. Anal Biochem. 1998;265:103-116.
6. Dekker J, Rossen JWA, Buller HA, et al. The MUC family: an obituary. Trends Biochem Sci. 2002;27:126-131.
7. Baldus SE, Hanisch FG. Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia. Adv Cancer Res. 2000;79:201-248.
8. Gendler SJ, Spicer AP, Lalani EN, et al. Structure and biology of a carcinoma-associated mucin, MUC1. Am Rev Respir Dis. 1991;144(3 pt 2):S42-S47.
9. Patton S, Gendler SJ, Spicer AP. The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim Biophys Acta. 1995;1241:407-423.
10. Gum JR. Mucin genes and the proteins they encode: structure, diversity, and regulation. Am J Respir Cell Mol Biol. 1992;7:557-564.
11. Gum JR Jr, Hicks JW, Toribara NW, et al. Molecular cloning of human intestinal mucin (MUC2) cDNA: identification of the amino terminus and overall sequence similarity to preprovon Willebrand factor. J Biol Chem. 1994;269:2440-2446.
12. Meerzaman D, Charles P, Daskal E, et al. Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem. 1994;269:12932-12939.
13. Ho SB, Niehans GA, Lyftogt C, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993;53:641-651.
14. Audie JP, Janin A, Porchet N, et al. Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem. 1993;41:1479-1485.
15. Ho SB, Shekels LL, Toribara NW, et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 1995;55:2681-2690.
16. Zotter S, Hageman PC, Lossnitzer A, et al. Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 1988;11-12:55-101.
17. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem. 1990;265:15286-15293.
18. Chang S, Dohrman AF, Basbaum CB, et al. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology. 1994;107:28-36.
19. Copin MC, Devisme L, Buisine MP, et al. From normal respiratory mucosa to epidermoid carcinoma: expression of human mucin genes. Int J Cancer. 2000;86:162-168.
20. Buisine MP, Devisme L, Maunoury V, et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands, 1: stomach: a relationship to gastric carcinoma. J Histochem Cytochem. 2000;48:1657-1666.
21. Buisine MP, Devisme L, Degand P, et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands, 11: duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem. 2000;48:1667-1676.
22. Reis CA, David L, Nielsen PA, et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer. 1997;74:112-121.
23. Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int. 1997;47:813-830.
24. Kim YS, Gum JR, Crawley SC, et al. Mucin gene and antigen expression in biliopancreatic carcinogenesis. Ann Oncol. 1999;10(suppl 4):S51-S55.
25. Hayashi H, Kitamura H, Nakatani Y, et al. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization. Hum Pathol. 1999;30:378-383.
26. Albarracin CT, Jafri J, Montag AG, et al. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol. 2000;31:672-677.
27. O'Connell JT, Tomlinson JS, Roberts AA, et al. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol. 2002;161:551-564.
28. O'Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol. 2002;159:958-972.
29. Lee MJ, Lee HS, Kim WH, et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003;16:403-410.
30. Girling A, Bartkova J, Burchell J, et al. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer. 1989;43:1072-1076.
31. Walsh MD, Hohn BG, Thong W, et al. Mucin expression by transitional cell carcinomas of the bladder. Br J Urol. 1994;73:256-262.
32. Terada T, Ohta T, Sasaki M, et al. Expression of MUC apomucins in normal pancreas and pancreatic tumors. J Pathol. 1996;180:160-165.
33. Dong Y, Walsh MD, Cummings MC, et al. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumors. J Pathol. 1997;183:311-317.
34. Monges GM, Mathoulin-Portier MA, Acres RB, et al. Differential MUC 1 expression in normal and neoplastic human pancreatic tissue: an immunohistochemical study of 60 samples. Am J Clin Pathol. 1999;112:635-640.
35. Rahn JJ, Dabbagh L, Pasdar M, et al. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer. 2001;91:1973-1982.
36. Sivridis E, Giatromanolaki A, Koukourakis MI, et al. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance. Histopathology. 2002;40:92-100.
37. Leroy X, Copin MC, Devisme L, et al. Expression of human mucin genes in normal kidney and renal cell carcinoma. Histopathology. 2002;40:450-457.
38. Xing PX, Prenzoska J, Layton GT, et al. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst. 1992;84:699-703.
39. Gambus G, De Bolos C, Andreu D, et al. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody. Gastroenterology. 1993;104:93-102.
40. Ajioka Y, Allison LJ, Jass JR. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol. 1996;49:560-564.
41. Sakamoto H, Yonezawa S, Utsunomiya T, et al. Mucin antigen expression in gastric carcinomas of young and old adults. Hum Pathol. 1997;28:1056-1065.
42. Baldus SE, Zirbes TK, Engel S, et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer. 1998;79:133-138.
43. Utsunomiya T, Yonezawa S, Sakamoto H, et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of patients. Clin Cancer Res. 1998;4:2605-2614.
44. Taylor KL, Mall AS, Barnard RA, et al. Immunohistochemical detection of gastric mucin in normal and disease states. Oncol Res. 1998;10:465-473.
45. Chinyama CN, Marshall REK, Owen WJ, et al. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology. 1999;35:517-524.
46. Machado JC, Nogueira AMMF, Cameiro F, et al. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol. 2000;190:437-443.
47. Matsuda K, Masaki T, Watanabe T, et al. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Jpn J Clin Oncol. 2000;30:89-94.
48. Reis CA, David L, Carvalho F, et al. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem. 2000;48:377-388.
49. Lee HS, Lee HK, Kim HS, et al. MUC1, MUC2, MUC5AC and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. 2001;92:1427-1434.
50. Pinto-de-Sousa J, David L, Reis CA, et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 2002;440:304-310.
51. x antigens in colorectal adenocarcinoma. Histopathology. 2002;40:440-449.
52. Hanski C, Hofmeier M, Schmitt-Graff A, et al. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol. 1997;182:385-391.
53. O'Connell JT, Shao ZM, Drori E, et al. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol. 1998;29:1517-1523.
54. Chu JS, Chang KJ. Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast. Cancer Lett. 1999;142:121-127.
55. Feng H, Ghazizadeh M, Konishi H, et al. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. Jpn J Clin Oncol. 2002;32:525-529.
56. Matsukita S, Nomoto M, Kitajima S, et al. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology. 2003;42:26-36.
57. Carrato C, Balague C, De Bolos C, et al. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology. 1994;107:160-172.
58. Sasaki M, Nakanuma Y, Kim YS. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology. 1996;24:1074-1078.
59. Luttges J, Zamboni G, Longnecker D, et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-948.
60. Gurbuz, Kahlke V, Kloppel G. How do gastric carcinoma classification systems relate to mucin expression patterns? an immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch. 2002;440:505-511.
61. Kocer B, Soran A, Erdogan S, et al. Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int. 2002;52:470-477.
62. Kim GE, Bae HI, Park HU, et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology. 2002;123:1052-1060.
63. Baldus SE, Monig SP, Arkenau V, et al. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma. Ann Surg Oncol. 2002;9:887-893.
64. Riethdorf L, O'Connell JT, Riethdorf S, et al. Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri. Virchows Arch. 2000;437:365-371.
65. Lopez-Ferrer A, Curull V, Barranco C, et al. Mucins as differentiation markers in bronchial epithelium: squamous cell carcinoma and adenocarcinoma display similar expression patterns. Am J Respir Cell Mol Biol. 2001;24:22-29.
66. Pereira MB, Dias AJ, Reis CA, et al. Immunohistochemical study of expression of MUC5AC and MUC6 in breast carcinomas and adjacent breast tissues. J Clin Pathol. 2001;54:210-213.
67. Chu PG, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms: frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol. 2000;113:374-382.
68. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody "Renal Cell Carcinoma Marker." Am J Surg Pathol. 2001;25:1485-1492.
69. Chu PG, Ishizawa S, Wu E, et al. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978-988.
70. Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33:1175-1181.